Llwytho...
Tositumomab and Iodine I 131 Tositumomab (Bexaar)
Tositumomab and iodine I 131 tositumomab (Bexaar) therapeutic regimen targets monoclonal antibodies against the CD20 antigen expressed in non-Hodgkin lymphoma. This article reviews the mechanism of action and clinical indications for this regimen.
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | AJNR Am J Neuroradiol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Society of Neuroradiology
2011
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7965875/ https://ncbi.nlm.nih.gov/pubmed/21436340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A2593 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|